Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
25 Results for "
isocitrate dehydrogenase 1 (IDH1)
" in MedChemExpress (MCE) Product Catalog:
Products (25)
25 Results for "isocitrate dehydrogenase 1 (IDH1)" in MCE Product Catalog:
8
8 Publications Verification
Cat. No.: HY-19540
CAS No.: 1816331-66-4
Target:
Research Areas:
GSK864, a chemical probe, is an isocitrate dehydrogenase 1 (IDH1) mutant inhibitor; inhibits IDH1 mutants R132C, R132H, and R132G with IC50 values of 8.8, 15.2 and 16.6 nM.
7
Target:
Research Areas:
Vorasidenib (AG-881) is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor. Vorasidenib (AG-881) exhibits nanomolar inhibition of (D)-2-hydroxyglutarate (D-2-HG), and the IC50 ranges of 0.04~22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H and IDH1 R132S and 7~14 nM against IDH2 R140Q and 130 nM against IDH2 R172K. Vorasidenib can be used for the study of grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1/2 mutation .
3
Target:
Research Areas:
Olutasidenib (FT-2102) is a highly potent, orally active, brain penetrant and selective inhibitor of mutant Isocitrate dehydrogenase 1 (IDH1), with IC50 values of 21.2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively . Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) .
3
3 Cited Publications
Target:
Research Areas:
BAY-1436032 is a novel pan-mutant isocitrate dehydrogenase 1 (IDH1) inhibitor.
2
2 Cited Publications
Target:
Research Areas:
DS-1001b is an orally active, blood-brain permeable, potent IDH-1 (isocitrate dehydrogenase-1) mutant inhibitor. DS-1001b has antitumor activity .
Target:
Research Areas:
(R,R)-GSK321 is a wild-type isocitrate dehydrogenase 1 (WT IDH1) inhibitor with an IC50 value of 120 nM. (R,R)-GSK321 as a mutant R132H IDH1 inhibitor, is an isomer of GSK321 with some wild-type cross reactivity .
Cat. No.: HY-41648
CAS No.: 1448346-63-1
Target:
Research Areas:
IDH1 Inhibitor 8 (91) is isocitrate dehydrogenase 1 (IDH1) inhibitor. IDH1 Inhibitor 8 can be used for the research of cancer .
Target:
Research Areas:
IDH889 is an orally available, brain penetrant, allosteric and mutant specific inhibitor of isocitrate dehydrogenase 1 (IDH1). IDH889 has potent selectivity for IDH1 R132* mutations, with IC50s of 0.02 μM, 0.072 μM and 1.38 μM for IDH1 R132H, IDH1 R132C and IDH1 wt, respectively. IDH889 shows potent cellular inhibition of R-2-hydroxyglutarate (2-HG) production with an IC50 of 0.014 μM .
Cat. No.: HY-114459
CAS No.: 1416270-18-2
Target:
Research Areas:
Mutant IDH1-IN-4 (compound 434) is an inhibitor of mutant Isocitrate dehydrogenase 1 (IDH 1), with IC50 values of ≤ 0.5 μM for mutant IDH1 in R132H, HT1080 and U87R132H cells .
Cat. No.: HY-175213
Target:
Research Areas:
Mutant IDH1-IN-7 is a highly selective Isocitrate Dehydrogenase 1 (IDH1) R132H (IC50 = 0.26 μM, Kd = 2.1 μM)/R132C (IC50 = 1.1 μM) inhibitor. Mutant IDH1-IN-7 has no inhibitory effect on wild-type IDH1, IDH2-wt, and IDH2 R140Q. Mutant IDH1-IN-7 inhibits 2-Hydroxyglutarate (2-HG) production in U87-MG R132H cells (EC50 = 0.55 μM). Mutant IDH1-IN-7 exhibits moderate antiproliferative effects on U87-MG R132H and HT-1080 cells .
Cat. No.: HY-143306
CAS No.: 1940128-37-9
Target:
Research Areas:
IDH1 Inhibitor 5 (compound 2) is an IDH1 (isocitrate dehydrogenase 1) inhibitor. IDH1 Inhibitor 5 inhibits MOG cells and wild-type IDH1 glioma cells with expressing exogenous mutant IDH1 R132H protein with IC50s of 64.4 and 34.9 nM, respectively .
Cat. No.: HY-100476
CAS No.: 1648909-73-2
Target:
Research Areas:
Mutant IDH1-IN-3 (Compound 1) is a selective allosteric inhibitor of mutant isocitrate dehydrogenase 1 (IDH1). Mutant IDH1-IN-3 has an IC50 of 13 nM for R132H IDH1. Mutant IDH1-IN-3 inhibits the production of D-2-hydroxyglutaric acid (2HG) in cells. Mutant IDH1-IN-3 can be used in the study of cancer .
Cat. No.: HY-158319
CAS No.: 3040122-14-0
Research Areas:
Mutant IDH1/NAMPT-IN-1 (Compound 23h) is a dual inhibitor of mutant isocitrate dehydrogenase 1 (mutant IDH1) (IC50=14.93 nM) and nicotinamide phosphoribosyltransferase (NAMPT) (IC50=12.56 nM). Mutant IDH1/NAMPT-IN-1 can induce apoptosis. Mutant IDH1/NAMPT-IN-1 crosses the blood-brain barrier effectively .
Cat. No.: HY-P704086
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IDH1; NADP+-Specific isocitrate dehydrogenase; isocitrate dehydrogenase (NADP(+)) 1; isocitrate dehydrogenase 1 (NADP+); Oxalosuccinate Decarboxylase; Epididymis Secretory Protein Li 26; NADP(+)-Specific ICDH; isocitrate dehydrogenase (NADP(+)); Isocitrat
Species:
Human
Source:
E. coli
Cat. No.: HY-P70214A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IDH1; NADP+-Specific isocitrate dehydrogenase; isocitrate dehydrogenase (NADP(+)) 1; isocitrate dehydrogenase 1 (NADP+); Oxalosuccinate Decarboxylase; Epididymis Secretory Protein Li 26; NADP(+)-Specific ICDH; isocitrate dehydrogenase (NADP(+)); Isocitrat
Species:
Human
Source:
HEK293
Cat. No.: HY-121916
CAS No.: 1355446-05-7
Target:
Research Areas:
ML309 is a highly selective and potent inhibitor of the R132H mutant isocitrate dehydrogenase 1 (IDH1 R132H), with an IC50 of 96 nM. ML309 is a competitive inhibitor of α-KG, with a Ki value of 156 nM, and its inhibitory activity against the wild-type IDH1 is greater than 35 μM. ML309 effectively reduces the production of the tumor metabolite 2-HG in U87MG cells. ML309 can be used as a chemical probe to study the role of the mutant IDH1 in cancer .
Cat. No.: HY-112289B
CAS No.: 1429179-08-7
Target:
Research Areas:
(1R)-IDH889 is the isomer of IDH889 (HY-112289), and can be used as an experimental control. IDH889 is an orally available, brain penetrant, allosteric and mutant specific inhibitor of isocitrate dehydrogenase 1 (IDH1). IDH889 has potent selectivity for IDH1 R132* mutations, with IC50s of 0.02 μM, 0.072 μM and 1.38 μM for IDH1 R132H, IDH1 R132C and IDH1 wt, respectively. IDH889 shows potent cellular inhibition of R-2-hydroxyglutarate (2-HG) production with an IC50 of 0.014 μM .
Cat. No.: HY-P70214
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IDH1; NADP+-Specific isocitrate dehydrogenase; isocitrate dehydrogenase (NADP(+)) 1; isocitrate dehydrogenase 1 (NADP+); Oxalosuccinate Decarboxylase; Epididymis Secretory Protein Li 26; NADP(+)-Specific ICDH; isocitrate dehydrogenase (NADP(+)); Isocitrat
Species:
Human
Source:
HEK293
Cat. No.: HY-P704085
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IDH1; NADP+-Specific isocitrate dehydrogenase; isocitrate dehydrogenase (NADP(+)) 1; isocitrate dehydrogenase 1 (NADP+); Oxalosuccinate Decarboxylase; Epididymis Secretory Protein Li 26; NADP(+)-Specific ICDH; isocitrate dehydrogenase (NADP(+)); Isocitrat
Species:
Human
Source:
E. coli
Cat. No.: HY-P704669
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IDH1; NADP+-Specific isocitrate dehydrogenase; isocitrate dehydrogenase (NADP(+)) 1; isocitrate dehydrogenase 1 (NADP+); Oxalosuccinate Decarboxylase; Epididymis Secretory Protein Li 26; NADP(+)-Specific ICDH; isocitrate dehydrogenase (NADP(+)); Isocitrat
Species:
Human
Source:
E. coli
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
